Literature DB >> 11877392

Protein kinase C and calcium/calmodulin-activated protein kinase II (CaMK II) suppress nicotinic acetylcholine receptor gene expression in mammalian muscle. A specific role for CaMK II in activity-dependent gene expression.

Peter Macpherson1, Tatiana Kostrominova, Huibin Tang, Daniel Goldman.   

Abstract

Nicotinic acetylcholine receptor (nAChR) gene expression is regulated by both muscle activity and increased intracellular calcium. This regulation is an important developmental event that rids receptors from the extrajunctional region of the developing muscle fiber. In avian muscle, it has been proposed that muscle activity suppresses nAChR gene expression via calcium-activated protein kinase C (PKC)-dependent phosphorylation of the myogenic transcription factor, myogenin. Here, we examined the role that PKC and other kinases play in mediating calcium- and activity-dependent suppression of nAChR genes in rat primary myotubes. We found that although activated PKC could regulate nAChR promoter activity and transiently suppressed both nAChR and myogenin gene expression, it did not appear to be required for calcium- or activity-dependent control of nAChR gene expression in mammalian muscle. Neither depletion of PKC from myotubes nor specific pharmacological inhibition of PKC blocked the suppression of nAChR gene expression produced by calcium or muscle depolarization. In contrast, we provide evidence that calcium/calmodulin-activated protein kinase II participates in mediating the effects of muscle depolarization on nAChR and myogenin gene expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11877392     DOI: 10.1074/jbc.M109864200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Activity-dependent gene regulation in skeletal muscle is mediated by a histone deacetylase (HDAC)-Dach2-myogenin signal transduction cascade.

Authors:  Huibin Tang; Daniel Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

2.  A highly conserved molecular switch binds MSY-3 to regulate myogenin repression in postnatal muscle.

Authors:  Libera Berghella; Luciana De Angelis; Tristan De Buysscher; Ali Mortazavi; Stefano Biressi; Sonia V Forcales; Dario Sirabella; Giulio Cossu; Barbara J Wold
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

3.  IP3 receptors and associated Ca2+ signals localize to satellite cells and to components of the neuromuscular junction in skeletal muscle.

Authors:  Jeanne A Powell; Jordi Molgó; Dany S Adams; Cesare Colasante; Aislinn Williams; MacKenzie Bohlen; Enrique Jaimovich
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

4.  Accelerated response of the myogenin gene to denervation in mutant mice lacking phosphorylation of myogenin at threonine 87.

Authors:  Chris S Blagden; Larry Fromm; Steven J Burden
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

5.  Molecular control of neuromuscular junction development.

Authors:  Elisabetta Ferraro; Francesca Molinari; Libera Berghella
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-10-14       Impact factor: 12.910

6.  Analgesic effects of Marasmius androsaceus mycelia ethanol extract and possible mechanisms in mice.

Authors:  Jia Song; Xue Wang; Yu Huang; Yidi Qu; Guirong Zhang; Di Wang
Journal:  Braz J Med Biol Res       Date:  2018-03-01       Impact factor: 2.590

Review 7.  The Neuromuscular Junction in Health and Disease: Molecular Mechanisms Governing Synaptic Formation and Homeostasis.

Authors:  Pedro M Rodríguez Cruz; Judith Cossins; David Beeson; Angela Vincent
Journal:  Front Mol Neurosci       Date:  2020-12-03       Impact factor: 5.639

8.  The calmodulin-dependent protein kinase II inhibitor KN-93 protects rat cerebral cortical neurons from N-methyl-D-aspartic acid-induced injury.

Authors:  Xuewen Liu; Cui Ma; Ruixian Xing; Weiwei Zhang; Buxian Tian; Xidong Li; Qiushi Li; Yanhui Zhang
Journal:  Neural Regen Res       Date:  2013-01-15       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.